Drug Eluting Stent
- UID
- MFG/MD/2023/000475_d54e4aab53783a99ea3989a3d6573296_9b60375db7fc89d88c8dcdeed73ab706
- Device class
- Class D
- Brand name
- Sirolimus
- License holder
- Newtech Medical Devices Pvt. Ltd.
- Approving authority
- Sub Zonal Baddi
- Product information
- Everolimus Coronary Stent System is indicated for improving coronary lumia diameters in patients including those with diabetes, mellitus with symptomatic ischemic heart disease Stable angina Unstable angina non-ST elevation documented due to arthersclerotic lesions in native coronary arteries.
Drug Eluting Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2023/000475_d54e4aab53783a99ea3989a3d6573296_9b60375db7fc89d88c8dcdeed73ab706. This device is marketed under the brand name Sirolimus. The license holder is Newtech Medical Devices Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Sub Zonal Baddi.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.